Close
Blake Borgeson and Chris Gibson, Co-Founders of Recursion Pharmaceuticals
Blake Borgeson and Chris Gibson, Co-Founders of Recursion Pharmaceuticals

AI and computer vision for drug discovery

Timeline

2013

 - Founded

2017

 - Partnered 

April 2021 - IPO (RXRX)

Bloomberg, Recursion Pharmaceuticals Expands IPO to Raise $436 Million

Recursion
Recursion

MedCityNews, With new $600M fund, CRV expands into bioengineering investment, adds strategic growth stage deals

TechCrunch, Drug discovery startup Recursion raises $60 million in Series B from Data Collective

Recursion